Feb 12 (Reuters)-
D.Western Therapeutics Institute Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2020 Dec 31, 2019 Dec 31, 2021 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 355 mln 580 mln 340 mln
(-38.7 pct) (+98.2 pct) (-4.4 pct)
Operating loss 265 mln 117 mln loss 580 mln
Recurring loss 289 mln 109 mln loss 580 mln
Net
Net loss 276 mln 133 mln loss 530 mln
EPS loss 10.16 yen 5.07 yen loss 18.12 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - D.Western Therapeutics Institute Inc.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4576.T